Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2021-02-26 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20210226 - Disposals of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled 'Disposals of own shares' and details transactions where UCB SA/NV disposed of its own shares following the exercise of stock options by personnel under the Long Term Incentive Program. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares. The appropriate filing type code is 'POS' (Transaction in Own Shares). The document length is short (2082 chars), but it is a substantive announcement detailing the transaction, not merely announcing the publication of a report.
2021-02-26 English
20210226 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA disposed of its own shares following option exercises by employees. The transactions involve specific dates, quantities, and prices for the shares alienated. This directly corresponds to the definition of a company reporting the repurchase or sale of its own shares. The filing type code matching this activity is 'POS' (Transaction in Own Shares). The document is a direct report of the transaction, not an announcement of a report, and its length is short (2205 chars), but the content is the primary data, not a pointer to another document.
2021-02-26 French
20210226 - Vervreemding van eigen aandelen.pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details specific transactions where UCB NV disposed of its own shares following the exercise of options by employees under long-term incentive plans. This directly corresponds to the definition of a company reporting transactions involving its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is short and appears to be a regulatory disclosure, not a full report, confirming the specific classification over a general one like RNS.
2021-02-26 Dutch
2020 IAR - ENG.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'INTEGRATED ANNUAL REPORT 2020' and contains comprehensive sections including financial performance, management reports, consolidated financial statements, and auditor's reports. It covers the full fiscal year 2020 and provides detailed business and financial analysis, fitting the definition of an Annual Report (10-K). FY 2020
2021-02-25 English
2020 integrated annual report - FR.pdf
Annual Report Classification · 100% confidence The document is titled 'RAPPORT ANNUEL INTÉGRÉ 2020' (2020 Integrated Annual Report) for UCB. It contains comprehensive financial statements, management reports, governance disclosures, and audit reports for the full fiscal year 2020. It is clearly the primary annual report of the company, not an announcement or a summary. FY 2020
2021-02-25 French
2020 integrated annual report - NL.pdf
Annual Report Classification · 100% confidence The document is titled 'GEÏNTEGREERD JAARVERSLAG 2020' (Integrated Annual Report 2020) for the company UCB. It contains comprehensive financial data, management reports, governance statements, and audit information for the full fiscal year 2020. It is clearly the primary annual reporting document, not an announcement or a summary. FY 2020
2021-02-25 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.